small cell lung cancer survival rate with treatment
Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf
... morphological characteristics of permanent human small cell lung cancer cell lines. J Cancer Res Clin Oncol 1987, 113:31-40. 16. NCCN guidelines for small- cell lung cancer. [http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp]. 17. ... in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9. 2. Murray N, Turrisi AT: A review of first-line treatment for small- cell lung cancer. J Thorac ... limited-stage small cell lung cancer. [http:// clinicaltrials.gov/ct2/show/NCT00433563]. 27. Three different radiation therapy regimens in treating patients with limited-stage small cell lung cancer...
Ngày tải lên: 09/08/2014, 09:20
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156. 2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis ... versus cisplatin-teniposide in patients with advanced non -small- cell lung cancer. The European Organi- zation for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1998, ... D: Comparison of survival and quality of life in advanced non -small- cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin:...
Ngày tải lên: 18/06/2014, 15:20
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
... Non -small- cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... L, Mok T, Rosell R, Klughammer B: Clinical outcomes in non -small- cell lung cancer patients with EGFR mutations: pooled analysis. J Cell Mol Med 2009, 14(1-2):51-69. 7. Marchetti A, Martella C, ... in non- small- cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. ...
Ngày tải lên: 18/06/2014, 16:20
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
... Carteni’ 1 Abstract Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC), presenting with metastatic mediastinal lymph nodes, is challenging. ... Access Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi 1* , Giuseppe Di Lorenzo 1 , Carlo ... treatment. Introduction In non -small cell lung cancer (NSCLC), mediastinal lymphnode involvement comprises a wide spectrum of severity. In fact, while 9% of patients with IIIA-N2 NSCLC is candidate...
Ngày tải lên: 09/08/2014, 03:21
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
... of clinical and dosimetric factors associated with treatment- related pneumonitis (TRP) in patients with non -small- cell lung cancer (NSCLC) treated with concurrent chemotherapy and three- dimensional ... Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non -small- cell lung cancer (NSCLC) and an increased risk of treatment complications: ... clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non -small cell lung cancer treated with concurrent chemotherapy and intensity-modulated...
Ngày tải lên: 09/08/2014, 08:23
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
... iotherapy, Oligometastases, Non -Small Cell Lung Cancer Background Non -small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States [1]. Patients with stage IV NSCLC typically ... for metastatic non small cell lung cancer (NSCLC) includes palliative systemic chemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intent stereotactic ... disease control and survival outcomes. In patients with non-metastatic NSCLC, numerous studies suggest that tumor burden corr elates with prog- nosis [27-30]. In a small cohort of 19 patients with stage I-III...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: " Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer" potx
... 115 patients with non -small cell lung cancer treated at our institution with definitive radiation therapy with or without concurrent chemotherapy (CHT). All patients were treated with 3D-CRT, ... energy agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non -small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2008, 72(2):335-342. 6. Therasse P, ... response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Insti- tute of the United States, National Cancer Institute of Can- ada. J Natl Cancer...
Ngày tải lên: 09/08/2014, 09:22
Báo cáo khoa học: " Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer" pot
... overall survival rates are 78% and 56%, cancer spe- cific survival rates (CSS) are 90% and 74% (Figure 3), and local relapse free survival rates are 93% and 76% respec- tively. Median overall survival ... toxicity. Actuarial 1 and 2-year overall survival rates are 78% and 56%, cancer specific survival rates (CSS) are 90% and 74%, and local relapse free survival rates are 93% and 76% respectively. Conclusion: ... as lung cancer. It is more convenient for the patients and reduces health care costs. This study reports our results on patients with medically inoperable, early stage, non -small cell lung cancer...
Ngày tải lên: 09/08/2014, 10:21
báo cáo khoa học: "EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features" pptx
Ngày tải lên: 10/08/2014, 10:21
Báo cáo y học: " Dual paraneoplastic syndromes in a patient with small cell lung cancer: a case report" pdf
Ngày tải lên: 10/08/2014, 23:22
Báo cáo y học: " Simulating non-small cell lung cancer with a multiscale agent-based model" doc
Ngày tải lên: 13/08/2014, 16:21
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt
... divided into two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer (NSCLC). All major histological types of lung cancer are associated with smoking, although the association ... act as a risk marker of lung cancer in Taiwan. Cancer 2003, 97:1558-1563. 11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65:13-18. 12. ... oesophagus, head and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate the hypothesis of HPV involvement in small cell lung cancer pathogenesis...
Ngày tải lên: 18/06/2014, 16:20
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
... marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007, 13:6649-57. 24. World Health Organization: Histological Typing of Lung and Pleural Tumours. ... patients treated with adjuvant chemotherapy after complete resection of non -small cell lung carcinoma. Cancer Res 2010, 70:8288-98. 19. Goldstraw P: The 7th Edition of TNM in Lung Cancer: what now? ... Paclitaxel-carboplatin alone or with bevacizumab for non -small- cell lung cancer. N Engl J Med 2006, 355:2542-50. 21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol 2007, 18(Suppl...
Ngày tải lên: 18/06/2014, 16:20